Skip to main content

News from Asia Pacific: Due to delayed marriages and the rising cost of living, Taiwan has one of the lowest fertility rates in the world, but is also one of the preferred destinations for assisted reproduction in Asia. Against this backdrop, INVO Bioscience Inc recently signed an exclusive agreement with Ming Mei Technology to distribute INVOcell intravaginal culture (IVC) system. This is expected to bring the latest and most advanced assisted fertility treatments to individuals in Taiwan.

Demand for fertility treatments set to increase

GlobalData, a leading data, and analytics company reports that the growth prospects for advanced assisted fertility treatments in Taiwan is gaining momentum. They say the latest exclusive agreement between INVO Bioscience with Ming Mei Technology which will most likely be a catalyst for more growth in treatment protocols for infertility.

INVO Bioscience Inc aims to take advantage of Ming Mei’s reproductive medicine expertise and strong customer relationships to strengthen its presence in the region.

How the treatment works

Pratibha Thammanabhatla, Medical Devices Analyst at GlobalData, told media that IVC allows an expectant mother to carry the embryo inside her body instead of leaving it in the lab, making the process more natural, intimate, and affordable compared to other assisted reproductive technology (ART) treatments.

“The demand for this treatment is expected to increase in Taiwan as INVO Bioscience Inc claims that success rates with this technique are comparable to in vitro fertilization and substantially higher than intrauterine insemination.”

Taiwan is one of the fasted growing ART device markets in Asia Pacific

GlobalData’s report, “Assisted Reproductive Technology Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030,” reveals that Taiwan is one of the fastest growing ART device markets in the Asia-Pacific region, growing at a compound annual growth rate of over 9% through 2030.

Thammanabhatla concludes: “With the availability of expertise, advanced treatment options, superior laboratory facilities, patient-centered customized treatment plans, and significant support from the Taiwanese government in the form of financial subsidy for assisted fertility services, the number of couples undergoing ART therapy in Taiwan is anticipated to grow rapidly and more companies are expected to invest in this space.

“As Taiwan lifts all its COVID-19 travel restrictions, medical tourism is also expected to increase.  International patients prefer ART treatment in Taiwan considering the affordability and convenience.”

References

Read more about the declining sperm count among men globally.

fertility and sperm count

kenary820/Shutterstock

Em Sloane

Em Sloane

I am an introverted nature lover, and long time contributor to LongevityLive.com. My role is to publish the information in a consumer friendly format, which we receive on the latest medical news, press releases and general information on the latest longevity related research findings.

Longevity Live is a digital publisher AND DOES NOT OFFER PERSONAL HEALTH OR MEDICAL ADVICE. IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY NUTRITION, DIET, EXERCISE, FITNESS, MEDICAL, OR WELLNESS PROGRAM.

This content, developed through collaboration with licensed medical professionals and external contributors, including text, graphics, images, and other material contained on the website, apps, newsletter, and products (“Content”), is general in nature and for informational purposes only and does not constitute medical advice; the Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.

Longevity Live makes no guarantees about the efficacy or safety of products or treatments described in any of our posts. Any information on supplements, related services and drug information contained in our posts are subject to change and are not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Longevity does not recommend or endorse any specific test, clinician, clinical care provider, product, procedure, opinion, service, or other information that may be mentioned on Longevity’s websites, apps, and Content.

error: Content is protected !!